Luigi Lenaz

Director/Board Member at

Allos Therapeutics, Inc.

85 year

83 connections

Health Technology

Commercial Services

Health Services

Profile

Luigi Lenaz is a member of various medical organizations such as the American Society of Clinical Oncology, the American Association for Cancer Research, the European Society for Medical Oncology, and the International Association for the Study of Lung Cancer.
He is also a director at Allos Therapeutics, Inc. and a former senior medical director at Bristol Myers Squibb Co. Additionally, he was a lead independent director at Spectrum Pharmaceuticals, Inc. and a chief scientific officer at the same company.
He was also a senior VP of clinical research and medical affairs at SuperGen, Inc. and a director at Pharmaco-Kinesis Corp.
Dr. Lenaz holds a doctorate degree from Alma Mater Studiorum - Università di Bologna.

Luigi Lenaz active positions

Companies	Position	Start
American Association for Cancer Research American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer	Corporate Officer/Principal	2010-06-28
American Society of Clinical Oncology, Inc. American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services	Corporate Officer/Principal	2010-06-28
European Society for Medical Oncology European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society	Corporate Officer/Principal	2010-06-28
International Association for the Study of Lung Cancer International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a multidisciplinary organization dedicated to the study, research, and eradication of lung cancer and other thoracic malignancies. The non-profit company is based in Aurora, CO. It serves a diverse community including oncologists, thoracic specialists, scientists, patient advocates, and caregivers, advancing lung cancer care through collaborative science, education, advocacy, and clinical practice. IASLC organizes major conferences, supports scientific projects, develops resources for targeted therapy, and publishes journals focused on thoracic oncology. The organization fosters professional development, provides educational materials, policy toolkits, patient advocacy initiatives, and training workshops to improve lung cancer diagnosis, treatment, and prevention.	Corporate Officer/Principal	2010-06-28
Allos Therapeutics, Inc. Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics	Director/Board Member	2012-09-04

All active positions of Luigi Lenaz

Former positions of Luigi Lenaz

Companies	Position	End
SPECTRUM PHARMACEUTICALS, INC.	Director/Board Member	2018-06-17
Pharmaco-Kinesis Corp. Pharmaco-Kinesis Corp. Miscellaneous Commercial ServicesCommercial Services Provides research and development services	Director/Board Member	2013-12-31
SPECTRUM PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	2008-05-31
SuperGen, Inc. SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products	Chief Tech/Sci/R&D Officer	2000-05-31
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

See the detail of Luigi Lenaz's experience

Training of Luigi Lenaz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Luigi Lenaz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
SuperGen, Inc. SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products	Health Technology
Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products	Health Technology
Allos Therapeutics, Inc. Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics	Health Technology
Pharmaco-Kinesis Corp. Pharmaco-Kinesis Corp. Miscellaneous Commercial ServicesCommercial Services Provides research and development services	Commercial Services
Alma Mater Studiorum - Università di Bologna Alma Mater Studiorum - Università di Bologna Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
American Society of Clinical Oncology, Inc. American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services	Health Services
American Association for Cancer Research American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer	Commercial Services
European Society for Medical Oncology European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society	Health Services
International Association for the Study of Lung Cancer International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a multidisciplinary organization dedicated to the study, research, and eradication of lung cancer and other thoracic malignancies. The non-profit company is based in Aurora, CO. It serves a diverse community including oncologists, thoracic specialists, scientists, patient advocates, and caregivers, advancing lung cancer care through collaborative science, education, advocacy, and clinical practice. IASLC organizes major conferences, supports scientific projects, develops resources for targeted therapy, and publishes journals focused on thoracic oncology. The organization fosters professional development, provides educational materials, policy toolkits, patient advocacy initiatives, and training workshops to improve lung cancer diagnosis, treatment, and prevention.	Commercial Services